Adam Zdeněk, Řehák Zdeněk, Adamová Zuzana, Koukalová Renata, Pour Luděk, Krejčí Marta, Boichuk Ivanna, Sandecká Viera, Krejčí Martin, Štork Martin, Ševčíková Sabina, Král Zdeněk
Vnitr Lek. 2022 Winter;68(1):41-53.
Castleman disease (CD) describes a group of heterogeneous hematologic disorders with characteristic histopathological features. CD can present with unicentric (UCD) or multicentric (MCD) regions of lymph node enlargement. Some cases of MCD are caused by human herpesvirus-8 (HHV-8), whereas others are HHV-8-negative/idiopathic (iMCD). Treatment of iMCD is challenging, and outcomes can be poor. In this paper, we briefly report about symptoms of iMCD and about the International, evidencebased consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease and International evidence based consensus treatment guidelines for idiopathic multicentric Castleman disease.
Castleman病(CD)是一组具有特征性组织病理学特征的异质性血液系统疾病。CD可表现为淋巴结肿大的单中心型(UCD)或多中心型(MCD)。部分MCD病例由人类疱疹病毒8型(HHV-8)引起,而其他病例为HHV-8阴性/特发性(iMCD)。iMCD的治疗具有挑战性,预后可能较差。在本文中,我们简要报告了iMCD的症状、HHV-8阴性/特发性多中心Castleman病的国际循证共识诊断标准以及特发性多中心Castleman病的国际循证共识治疗指南。